Research ArticleCancer
Targeted antibody and cytokine cancer immunotherapies through collagen affinity
- Jun Ishihara1,*,
- Ako Ishihara1,*,
- Koichi Sasaki1,†,
- Steve Seung-Young Lee2,
- John-Michael Williford1,
- Mariko Yasui3,
- Hiroyuki Abe3,
- Lambert Potin1,4,
- Peyman Hosseinchi1,
- Kazuto Fukunaga1,‡,
- Michal M. Raczy1,
- Laura T. Gray1,
- Aslan Mansurov1,
- Kiyomitsu Katsumata1,§,
- Masashi Fukayama3,
- Stephen J. Kron2,
- Melody A. Swartz1,5 and
- Jeffrey A. Hubbell1,||
- 1Institute for Molecular Engineering, University of Chicago, Chicago, IL 60637, USA.
- 2Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL 60637, USA.
- 3Department of Pathology, University of Tokyo, 113-8655 Tokyo, Japan.
- 4Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
- 5Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA.
- ↵||Corresponding author. Email: jhubbell{at}uchicago.edu
↵* These authors contributed equally to this work.
↵† Present address: Department of Applied Chemistry, Faculty of Engineering, Kyushu University, 819-0395 Fukuoka, Japan.
↵‡ Present address: FUJIFILM Corporation, 258-8577 Kanagawa, Japan.
↵§ K.K. is on leave from Astellas Pharma Inc.
See allHide authors and affiliations
Science Translational Medicine 10 Apr 2019:
Vol. 11, Issue 487, eaau3259
DOI: 10.1126/scitranslmed.aau3259
